Cart (0)
  • No items in cart.
Total
$0
There is a technical issue about last added item. You can click "Report to us" button to let us know and we resolve the issue and return back to you or you can continue without last item via click to continue button.
Search book title
Enter keywords for book title search
Search book content
Enter keywords for book content search
Filters:
FORMAT
BOOKS
PACKAGES
EDITION
to
PUBLISHER
(1)
(326)
(573)
(44)
(234)
(969)
(652)
(2114)
(64)
(92448)
(54)
(541)
(117)
(33)
(20)
(20)
(93277)
(3)
(17)
(1)
(351)
(300)
(6217)
(240)
(16)
(5)
(1635)
(16)
(19)
(28)
(4)
 
(6)
(7)
(115)
(3)
(57)
(5)
(5)
(1)
(1)
(2)
(25)
(26)
(27)
(13)
(61)
(24)
(22)
(7)
(8)
(20)
(1)
(3)
(50)
(6)
(31)
CONTENT TYPE
 Act
 Admin Code
 Announcements
 Bill
 Book
 CADD File
 CAN
 CEU
 Charter
 Checklist
 City Code
 Code
 Commentary
 Comprehensive Plan
 Conference Paper
 County Code
 Course
 DHS Documents
 Document
 Errata
 Executive Regulation
 Federal Guideline
 Firm Content
 Guideline
 Handbook
 Interpretation
 Journal
 Land Use and Development
 Law
 Legislative Rule
 Local Amendment
 Local Code
 Local Document
 Local Regulation
 Local Standards
 Manual
 Model Code
 Model Standard
 Notice
 Ordinance
 Other
 Paperback
 PASS
 Periodicals
 PIN
 Plan
 Policy
 Product
 Product - Data Sheet
 Program
 Provisions
 Requirements
 Revisions
 Rules & Regulations
 Standards
 State Amendment
 State Code
 State Manual
 State Plan
 State Standards
 Statute
 Study Guide
 Supplement
 Technical Bulletin
 All
  • BSI
    BS EN ISO 21676:2021 Water quality. Determination of the dissolved fraction of selected active pharmaceutical ingredients, transformation products and other organic substances in water and treated waste water. Method using high performance liquid chromatography and mass spectrometric detection (HPLC-MS/MS or -HRMS) after direct injection
    Edition: 2021
    $418.55
    / user per year

Description of BS EN ISO 21676:2021 2021

This document specifies a method for the determination of the dissolved fraction of selected active pharmaceutical ingredients and transformation products, as well as other organic substances (see Table 1) in drinking water, ground water, surface water and treated waste water.

The lower application range of this method can vary depending on the sensitivity of the equipment used and the matrix of the sample. For most compounds to which this document applies, the range is ≥ 0,025 µg/l for drinking water, ground water and surface water, and ≥ 0,050 µg/l for treated waste water.

The method can be used to determine further organic substances or in other types of water (e.g. process water) provided that accuracy has been tested and verified for each case, and that storage conditions of both samples and reference solutions have been validated. Table 1 shows the substances for which a determination was tested in accordance with the method. Table E.1 provides examples of the determination of other organic substances.

Table 1

Substances for which a determination was tested in accordance with this method

Common name
Chemical name (IUPACa )
Molecular
formula
Molar
mass
CAS-RNb
    g/mol  
4-Acetylaminoantipyrine

N-(2,3-Dimethyl-5-oxo-1-phenyl-3-pyrazolin-4-yl)acetamide

C13H15N3O2 245,28 83-15-8
N4-Acetyl sulfamethoxazole

N-{4-[(5-Methyl-1,2-oxazol-3-yl)sulfamoyl]phenyl}-acetamide

C12H13N3O4S 295,32 21312-10-7
Diatrizoic acid (amidotricoic acid)

3,5-Bis(acetamido)-2,4,6-triiodobenzoic acid

C11H9I3N2O4 613,91 117-96-4
Atenolol

(RS)-2-[4-[2-Hydroxy-3-(1-methylethylamino) propoxy]phenyl]ethanamide

C14H22N2O3 266,34 29122-68-7
Bezafibrate

2-{4-[2-(4-Chlorbenzamido)ethyl]phenoxyl}-2-
methylpropanoic acid

C19H20ClNO4 361,80 41859-67-0
Bisoprolol

(RS)-1-[4-(2-Isopropoxyethoxymethyl)phenoxy]-3-
isopropylamino-2-propanol

C18H31NO4 325,45 66722-44-9
Carbamazepine

5H-Dibenzo[b,f]azepine-5-carbamide

C15H12N2O 236,27 298-46-4
Clarithromycin

(2R,3R,4S,5R,8R,9S,10S,11R,12R,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-3,4-dihydroxy-9-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl]oxy-12-methoxy-2,4,8,10,12,14-hexa-
methyl-6-oxacyclotetradecane-1,7-dione

C38H69NO13 747,95 81103-11-9
Clofibric acid

2-(4-Chlorophenoxy)-2-methylpropanoic acid

C10H11ClO3 214,70 882-09-7
Dehydrato-Erythromycin (anhydro-erythromycin)

(2R,3R,4S,5S,8R,9S,10S,11R,12R)-11-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-5-ethyl-3-hydroxy-9-[(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy]-2,4,8,10,12,14-hexamethyl-6,15,16-trioxatricyclo[10.2.1.1{1,4}]hexadecane-7-one

C37H65NO12 715,91 23893-13-2
Diazepam

(RS)-7-Chlor-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-
benzodiazepine-2-on

C16H13ClN2O 284,74 439-14-5
Diclofenac

2-[2-[(2,6-Dichlorphenyl)amino]phenyl]acetic acid

C14H11Cl2NO2 296,15 15307-86-5
10,11-Dihydro-10,11-dihydroxy carbamazepine

(5S,6S)-5,6-Dihydroxy-5,6-dihydrobenzo[b][1]benzazepie-11-carboxamide

C15H14N2O3 270,29 58955-93-4
Erythromycin

6-(4-Dimethylamino-3-hydroxy-6-methyl-oxan-2-yl)oxy-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl)-oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione

C37H67NO13 733,93 114-07-8
4-Formylaminoantipyrine

N-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)formamide

C12H13N3O2 231,25 1672-58-8
Gemfibrozil

5-(2,5-Chlorophenoxy)-2,2-methylpropanoic acid

C15H22O3 250,34 25812-30-0
Ibuprofen

(RS)-2-[4-(2-Methylpropyl)phenyl]propanoic acid

C13H18O2 206,28 15687-27-1
Iomeprol

(±)-N,N′-Bis-(2,3-dihydroxypropyl)-5-[(2-hydroxy-acetyl)methylamino]-2,4,6-triiodo isophthalamide

C17H22I3N3O8 777,09 78649-41-9
Iopamidol

(S)-N,N′-Bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[(2-hydroxypropanoyl)amino]-2,4,6-triiodobenzene-1,3-dicarbamide

C17H22I3N3O3 777,08 60166-93-0
Iopromide

(±)-N,N′-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-
(2-methoxyacetamido)-N-methylisophthalamide

C18H24I3N3O8 791,12 73334-07-3
Metoprolol

(RS)-1-(Isopropylamino)-3-[4-(2-methoxyethyl) phenoxy]propan-2-ol

C15H25NO3 267,36 37350-58-6
Naproxen

(S)-2-(6-Methoxy-2-naphthyl)propanoic acid

C14H14O3 230,26 22204-53-1
Oxazepam

(RS)-7-Chloro-3-hydroxy-5-phenyl-1,3-dihydro-2H-1,4-
benzodiazepin-2-on

C15H11ClN2O2 286,71 604-75-1
Phenazone

1,5-Dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-on

C11H12N2O 188,23 60-80-0
Primidone

5-Ethyl-5-phenylhexahydropyrimidin-4,6-dione

C12H14N2O2 218,25 125-33-7
Propyphenazone

1,5-Dimethyl-4-(1-methylethyl)-2-phenyl-1,2-dihydro-3H-
pyrazol-3-one

C14H18N2O 230,31 479-92-5
Roxithromycin

(3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-10-(2,4,7-trioxa-1-azaoctan-1-ylidene)-1-
oxacyclotetradecane-2-one

C41H76N2O15 837,05 80214-83-1
Sotalol

(RS)-4′-(1-Hydroxy-2-isopropylaminoethyl)
methanesulfonanilide

C12H20N2O3S 272,36 3930-20-9
Sulfamethoxazole

4-Amino-N-(5-methyl-1,2-oxazol-3-yl)benzene-sulfonamide

C10H11N3O3S 253,28 723-46-6
Temazepam

(RS)-7-Chloro-3-hydroxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one

C16H13ClN2O2 300,74 846-50-4
Trimethoprim

2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine

C14H18N4O3 290,32 738-70-5

a IUPAC: International Union of Pure and Applied Chemistry.

b CAS-RN: Chemical Abstracts System Registration Number.



About BSI

BSI Group, also known as the British Standards Institution is the national standards body of the United Kingdom. BSI produces technical standards on a wide range of products and services and also supplies certification and standards-related services to businesses.

X